Hey Trader,
Gene therapy is projected to be one of the most lucrative corners of the stock market in the coming years.
According to 2020's top money manager, ARK founder Cathie Wood:
"The biggest upside surprises are going to come from the genomic space, and that's because the convergence of DNA sequencing, artificial intelligence, and gene therapies are going to cure disease."
That's great insight, but there's just one problem…
How can you identify the gene therapy companies with the greatest breakout potential?
There's one method that's helped investors find huge under-the-radar opportunities across all market sectors…
I'm talking about following company insiders.
Now Ross Givens has just spotted back-to-back insider buys at a gene therapy company with several promising programs under development.
The CEO and a high-level director each picked up around $100k worth of the stock.
What's more, the director is a first-time buyer…
And the CEO has a perfect track record on previous buys in similar firms.
Those are two key ingredients that signal huge profit potential on a setup like this.
Now Ross has already alerted his Insider Report members to this gene therapy ticker that's poised to potentially break out any day…
So if you'd like to learn more about this insider trading method…
Including why the "first-time buyer" and the "perfect track record" are such significant indications of a major opportunity…
Simply click here to view a free on-demand training video where all will be revealed.
To your trading success,
No comments:
Post a Comment